Edwards Lifesciences Corp Accounts Receivable 2009-2026 | EW
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is Edwards Lifesciences Corp's current accounts receivable?
Edwards Lifesciences Corp (EW) annual accounts receivable for 2025 was $659.6M, a 8.29% increase from 2024. Edwards Lifesciences Corp accounts receivable for the quarter ending March 31, 2026 was $775.7M.
What was Edwards Lifesciences Corp's accounts receivable in 2024?
Edwards Lifesciences Corp annual accounts receivable for 2024 was $609.1M, a 21.05% decline from 2023.
What was Edwards Lifesciences Corp's accounts receivable in 2023?
Edwards Lifesciences Corp annual accounts receivable for 2023 was $771.5M, a 19.98% increase from 2022.
What is Edwards Lifesciences Corp's 5-year accounts receivable CAGR?
Edwards Lifesciences Corp accounts receivable grew at a compound annual growth rate (CAGR) of 5.09% from FY2020 to FY2025, going from $514.6M to $659.6M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $659.6M | +8.3% | 10-K |
| FY2024 | $609.1M | -21.0% | 10-K |
| FY2023 | $771.5M | +20.0% | 10-K |
| FY2022 | $643.0M | +10.4% | 10-K |
| FY2021 | $582.2M | +13.1% | 10-K |
| FY2020 | $514.6M | -5.3% | 10-K |
| FY2019 | $543.6M | +19.0% | 10-K |
| FY2018 | $456.9M | +4.1% | 10-K |
| FY2017 | $438.7M | +20.0% | 10-K |
| FY2016 | $365.5M | +15.9% | 10-K |
| FY2015 | $315.4M | +9.5% | 10-K |
| FY2014 | $288.0M | -4.8% | 10-K |
| FY2013 | $302.5M | -5.8% | 10-K |
| FY2012 | $321.1M | +13.1% | 10-K |
| FY2011 | $283.8M | +2.3% | 10-K |
| FY2010 | $277.3M | +11.2% | 10-K |
| FY2009 | $249.4M | - | 10-K |